Evidence map›Paper›PMID 34850884›Full record

SynthesisHuman molecular genetics2022

Novel susceptibility loci for steroid-associated osteonecrosis of the femoral head in systemic lupus erythematosus.

Hiroyuki Suetsugu, Kwangwoo Kim, Takuaki Yamamoto, So-Young Bang, Yuma Sakamoto, Jung-Min Shin, Nobuhiko Sugano, Ji Soong Kim, Masaya Mukai, Yeon-Kyung Lee and 45 more

Open access · greenAbstract readMeta-Analysis
In one paragraph

Synthesis in Human molecular genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

55 authors at 20 institutions in 2 countries.

Hiroyuki SuetsuguLaboratory for Bone and Joint Diseases, RIKEN Center for Medical Sciences, Tokyo 108-8639, Japan.
Kwangwoo KimDepartment of Biology, Kyung Hee University, Seoul 02447, Republic of Korea.
Takuaki YamamotoDepartment of Orthopaedic Surgery, Faculty of Medicine, Fukuoka University, Fukuoka 814-0180, Japan.
So-Young BangDepartment of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul 04763, Korea.
Yuma SakamotoKoga Hospital 21, Fukuoka 839-0801, Japan.
Jung-Min ShinDepartment of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul 04763, Korea.
Nobuhiko SuganoDepartment of Orthopaedic Medical Engineering, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan.
Ji Soong KimDepartment of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul 04763, Korea.
Masaya MukaiDepartment of Rheumatology & Clinical Immunology, Sapporo City General Hospital, Hokkaido 060-8604, Japan.
Yeon-Kyung LeeDepartment of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul 04763, Korea.
Koichiro OhmuraDepartment of Rheumatology and Clinical Immunology, Kyoto University Graduate School of Medicine, Kyoto 606-8507, Japan.
Dae Jin ParkDepartment of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul 04763, Korea.
Daisuke TakahashiDepartment of Orthopaedic Surgery, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Hokkaido 060-8638, Japan.
Ga-Young AhnDepartment of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul 04763, Korea.
Kohei KarinoDepartment of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Hokkaido 060-8638, Japan.
Young-Chang KwonHanyang University Institute for Rheumatology Research, Seoul 04763, Korea.
Tomoya MiyamuraDepartment of Internal Medicine and Rheumatology, National Hospital Organization Kyushu Medical Center, Fukuoka 810-8563, Japan.
Jihye KimHanyang University Institute for Rheumatology Research, Seoul 04763, Korea.
Junichi NakamuraDepartment of Orthopaedic Surgery, Graduate School of Medicine, Chiba University, Chiba 260-8677, Japan.
Goro MotomuraDepartment of Orthopaedic Surgery, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan.
Takeshi KurodaNiigata University Health Administration Center, Niigata 950-2181, Japan.
Hiroaki NiiroDepartment of Medical Education, Kyushu University Graduate School of Medical Sciences, Fukuoka 812-8582, Japan.
Takeshi MiyamotoDepartment of Orthopaedic Surgery, Faculty of Life Sciences, Kumamoto University, Kumamoto 860-8556, Japan.
Tsutomu TakeuchiDivision of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo 160-8582, Japan.
Katsunori IkariInstitute of Rheumatology, Tokyo Women's Medical University, Tokyo 162-8666, Japan.
Koichi AmanoDepartment of Rheumatology & Clinical Immunology, Saitama Medical Center, Saitama Medical University, Saitama 350-8550, Japan.
Yoshifumi TadaDepartment of Rheumatology, Faculty of Medicine, Saga University, Saga 849-8501, Japan.
Ken YamajiDepartment of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Tokyo 113-8421, Japan.
Masato ShimizuHokkaido Medical Center for Rheumatic Diseases, Hokkaido 063-0811, Japan.
Takashi AtsumiDepartment of Orthopaedic Surgery, Showa University School of Medicine, Tokyo 142-8555, Japan.
Taisuke SekiDepartment of Orthopaedic Surgery, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.
Yoshiya TanakaThe First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Fukuoka 807-8555, Japan.
Toshikazu KuboGraduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan.
Ryo HisadaObihiro Kosei Hospital, Hokkaido 080-0024, Japan.
Tomokazu YoshiokaDivision of Regenerative Medicine for Musculoskeletal System, Faculty of Medicine, University of Tsukuba, Ibaraki 305-8575, Japan.
Mihoko YamazakiKido Hospital, Niigata 950-0862, Japan.
Tamon KabataDepartment of Orthopaedic Surgery, Graduate School of Medical Science, Kanazawa University, Kanazawa 920-8641, Japan.
Tomomichi KajinoDepartment of Orthopaedic Surgery, Tonan Hospital, Hokkaido 060-0004, Japan.
Yoichi OhtaDepartment of Orthopaedic Surgery, Osaka City University Graduate School of Medicine, Osaka 545-8585, Japan.
Takahiro OkawaOrthopedis and Joint Surgery Center, Kurume University Medical Center, Fukuoka 839-0863, Japan.
Yohei NaitoDepartment of Orthopaedic Surgery, Mie University Graduate School of Medicine, Mie 514-8507, Japan.
Ayumi KaneujiDepartment of Orthopaedic Surgery, Kanazawa Medical University, Ishikawa 920-0293, Japan.
Yuji YasunagaHiroshima Prefectural Rehabilitation Center, Hiroshima 739-0036, Japan.
Kenji OhzonoDepartment of Orthopaedic Surgery, Amagasaki Chuo Hospital, Hyogo 661-0976, Japan.
Kohei TomizukaLaboratory for Statistical and Translational Genetics Analysis, RIKEN Center for Integrative Medical Sciences, Kanagawa 230-0045, Japan.
Masaru KoidoLaboratory for Statistical and Translational Genetics Analysis, RIKEN Center for Integrative Medical Sciences, Kanagawa 230-0045, Japan.ORCID 0000-0002-0348-0666
Koichi MatsudaLaboratory of Genome Technology, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan.
Yukinori Okada44Department of Statistical Genetics, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan.ORCID 0000-0002-0311-8472
Akari SuzukiLaboratory for Autoimmune Diseases, RIKEN Center for Integrative Medical Sciences, Kanagawa 230-0045, Japan.
Bong-Jo KimDivision of Genome Research, Center for Genome Science, National Institute of Health, Osong Health Technology Administration Complex, Cheongju 28159, Korea.
Yuta KochiDepartment of Genomic Function and Diversity, Medical Research Institute, Tokyo Medical and Dental University, Tokyo 113-8510, Japan.
Hye-Soon LeeDepartment of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul 04763, Korea.
Shiro IkegawaLaboratory for Bone and Joint Diseases, RIKEN Center for Medical Sciences, Tokyo 108-8639, Japan.
Sang-Cheol BaeDepartment of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul 04763, Korea.
Chikashi TeraoLaboratory for Statistical and Translational Genetics Analysis, RIKEN Center for Integrative Medical Sciences, Kanagawa 230-0045, Japan.ORCID 0000-0002-6452-4095
Hanyang University Seoul Hospital · KRRIKEN Center for Integrative Medical Sciences · JPKyushu University · JPHokkaido University · JPThe University of Osaka · JPChiba University · JPFukuoka University · JPHanyang University · KRHiroshima Prefectural Rehabilitation Center · JPJuntendo University · JPKanazawa Medical University · JPKanazawa University · JPKeio University · JPKoga Hospital · JPKorea National Institute of Health · KRKumamoto University · JPKurume University Medical Center · JPKyoto Prefectural University of Medicine · JPKyoto University · JPKyung Hee University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Osteonecrosis of the femoral head (ONFH) involves necrosis of bone and bone marrow of the femoral head caused by ischemia with unknown etiology. Previous genetic studies on ONFH failed to produce consistent results, presumably because ONFH has various causes with different genetic backgrounds and the underlying diseases confounded the associations. Steroid-associated ONFH (S-ONFH) accounts for one-half of all ONFH, and systemic lupus erythematosus (SLE) is a representative disease underlying S-ONFH. We performed a genome-wide association study (GWAS) to identify genetic risk factors for S-ONFH in patients with SLE. We conducted a two-staged GWAS on 636 SLE patients with S-ONFH and 95 588 non-SLE controls. Among the novel loci identified, we determined S-ONFH-specific loci by comparing allele frequencies between SLE patients without S-ONFH and non-SLE controls. We also used Korean datasets comprising 148 S-ONFH cases and 37 015 controls to assess overall significance. We evaluated the functional annotations of significant variants by in silico analyses. The Japanese GWAS identified 4 significant loci together with 12 known SLE susceptibility loci. The four significant variants showed comparable effect sizes on S-ONFH compared with SLE controls and non-SLE controls. Three of the four loci, MIR4293/MIR1265 [odds ratio (OR) = 1.99, P-value = 1.1 × 10-9)], TRIM49/NAALAD2 (OR = 1.65, P-value = 4.8 × 10-8) and MYO16 (OR = 3.91, P-value = 4.9 × 10-10), showed significant associations in the meta-analysis with Korean datasets. Bioinformatics analyses identified MIR4293, NAALAD2 and MYO16 as candidate causal genes. MIR4293 regulates a PPARG-related adipogenesis pathway relevant to S-ONFH. We identified three novel susceptibility loci for S-ONFH in SLE.

Indexed as

Femur Head NecrosisLupus Erythematosus, SystemicSteroidsCarboxypeptidasesCarrier ProteinsFemur HeadGenetic Predisposition to DiseaseGenome-Wide Association StudyHumansMicroRNAsMyosin Heavy ChainsPolymorphism, Single NucleotideCarboxypeptidasesCarrier ProteinsMicroRNAsMIRN4293 microRNA, humanMYO16 protein, humanMyosin Heavy ChainsNAALAD2 protein, humanSteroidsTRIM49 protein, human

Identifiers

PMID34850884
PMCPMC8976424
OpenAlexW3214905835

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.